WASHINGTON, Feb. 1, 2017 /PRNewswire/ -- The Advisory Board Company (NASDAQ: ABCO) plans to report financial results forthe quarter and year ended December 31, 2016 after the market closes on Tuesday, February 28, 2017.
A conference call to discuss the Company's financial results is scheduled to be
To participate by telephone, please dial 888-336-7150 (or 1-412-902-4176 for international callers). Participants are advised to dial in at least five minutes prior to the call to register.
About The Advisory Board Company
The Advisory Board Company is a best practices firm that uses a combination of research, technology, and consulting to improve the performance of 5,500+ health care organizations and educational institutions. Headquartered in Washington, D.C., with offices worldwide, The Advisory Board Company forges and finds the best new ideas and proven practices from its network of thousands of leaders, then customizes and hardwires them into every level of member organizations, creating enduring value. For more information, visit www.advisoryboardcompany.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-advisory-board-company-to-report-fourth-quarter-and-year-end-financial-results-after-market-close-on-february-28-2017-300400516.html
SOURCE The Advisory Board Company
Subscribe to our Free Newsletters!
Snake antivenom is a medicine used for the treatment of patients suffering from snake envenomation.